BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 24428897)

  • 21. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study.
    Bouros D; Schiza S; Patsourakis G; Chalkiadakis G; Panagou P; Siafakas NM
    Am J Respir Crit Care Med; 1997 Jan; 155(1):291-5. PubMed ID: 9001327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions.
    Thommi G; Shehan JC; Robison KL; Christensen M; Backemeyer LA; McLeay MT
    Respir Med; 2012 May; 106(5):716-23. PubMed ID: 22398159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical versus non-surgical management for pleural empyema.
    Redden MD; Chin TY; van Driel ML
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010651. PubMed ID: 28304084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complicated parapneumonic effusion and empyema thoracis: microbiology and predictors of adverse outcomes.
    Tsang KY; Leung WS; Chan VL; Lin AW; Chu CM
    Hong Kong Med J; 2007 Jun; 13(3):178-86. PubMed ID: 17548905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrapleural fibrinolytic therapy for pleural infection.
    Bouros D; Tzouvelekis A; Antoniou KM; Heffner JE
    Pulm Pharmacol Ther; 2007; 20(6):616-26. PubMed ID: 17049447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrapleural Fibrinolytic Therapy versus Early Medical Thoracoscopy for Treatment of Pleural Infection. Randomized Controlled Clinical Trial.
    Kheir F; Thakore S; Mehta H; Jantz M; Parikh M; Chee A; Kaphle U; Sisnega C; Fernandez-Bussy S; Majid A
    Ann Am Thorac Soc; 2020 Aug; 17(8):958-964. PubMed ID: 32421353
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparing the outcomes of intrapleural fibrinolytic and DNase therapy versus intrapleural fibrinolytic or DNase therapy: A systematic review and meta-analysis.
    Chong WH; Hu K; Saha BK; Chopra A
    Pulm Pharmacol Ther; 2021 Dec; 71():102081. PubMed ID: 34571093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrapleural Fibrinolytic Therapy for Empyema and Pleural Loculation: Knowns and Unknowns.
    Idell S; Rahman NM
    Ann Am Thorac Soc; 2018 May; 15(5):515-517. PubMed ID: 29361235
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis.
    Janda S; Swiston J
    Chest; 2012 Aug; 142(2):401-411. PubMed ID: 22459772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a pediatric protocol of intrapleural urokinase for pleural empyema: a prospective study.
    Stefanutti G; Ghirardo V; Barbato A; Gamba P
    Surgery; 2010 Sep; 148(3):589-94. PubMed ID: 20304453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Variables for Failure in Administration of Intrapleural Tissue Plasminogen Activator/Deoxyribonuclease in Patients With Complicated Parapneumonic Effusions/Empyema.
    Khemasuwan D; Sorensen J; Griffin DC
    Chest; 2018 Sep; 154(3):550-556. PubMed ID: 29425674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas.
    Sahn SA
    Thorax; 1998 Aug; 53 Suppl 2(Suppl 2):S65-72. PubMed ID: 10193351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of fibrinolytic therapy for parapneumonic effusion in pregnancy: a case report and a review.
    Nasralla A; Laing B; Turner SR
    J Cardiothorac Surg; 2021 Aug; 16(1):236. PubMed ID: 34419110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children.
    Yao CT; Wu JM; Liu CC; Wu MH; Chuang HY; Wang JN
    Chest; 2004 Feb; 125(2):566-71. PubMed ID: 14769739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrapleural streptokinase in complicated parapneumonic effusions and empyema.
    Barthwal MS; Deoskar RB; Rajan KE; Chatterjee RS
    Indian J Chest Dis Allied Sci; 2004; 46(4):257-61. PubMed ID: 15515826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrapleural urokinase treatment in children with complicated parapneumonic effusion.
    Chen JP; Lue KH; Liu SC; Cheng SL; Sheu JN
    Acta Paediatr Taiwan; 2006; 47(2):61-6. PubMed ID: 16927629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parapneumonic pleural effusion and empyema.
    Koegelenberg CF; Diacon AH; Bolliger CT
    Respiration; 2008; 75(3):241-50. PubMed ID: 18367849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of fibrinolytic agents for draining intrapleural infections.
    Bouros D; Schiza S; Siafakas N
    Semin Respir Infect; 1999 Mar; 14(1):39-47. PubMed ID: 10197396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis.
    Lim TK; Chin NK
    Eur Respir J; 1999 Mar; 13(3):514-8. PubMed ID: 10232418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.